BEIJING, March 9 (Xinhua) -- About 2.84 billion yuan (around 434 million U.S. dollars) worth of medical bills related to COVID-19 treatment were paid in China in 2020, showed a report released by the country's National Healthcare Security Administration.
Besides, the funds granted by regional medical insurance departments to designated COVID-19 treatment facilities topped 19.4 billion yuan.
During the pandemic, the administration took swift measures to ensure that timely medical treatments for COVID-19 patients are not obstructed by payment issues.
The administration also brought medical supplies and medicines used in COVID-19 treatment under the ambit of medical insurance coverage, reducing the prices for nucleic acid test and antibody test reagents by more than 70 percent and 40 percent, respectively.